FIELD: medicine.
SUBSTANCE: for treating psoriasis an anti-IL-17 antibody is administered in effective doses in accordance with developed scheme of administration.
EFFECT: group of inventions provides effective treatment of psoriasis, including its recurrences, without aggravation of disease.
18 cl, 11 dwg, 11 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS OF TREATING PSORIASIS USING IL-17 ANTAGONISTS | 2011 |
|
RU2665954C1 |
USE OF IL-17 ANTAGONISTS FOR INHIBITION OF STRUCTURAL DAMAGE PROGRESSION IN PATIENTS WITH PSORIATIC ARTHRITIS | 2015 |
|
RU2697383C2 |
METHODS OF TREATING RHEUMATOID ARTHRITIS USING IL-17 ANTAGONISTS | 2011 |
|
RU2582937C2 |
METHODS OF TREATING NON-RADIOGRAPHIC AXIAL SPONDYLARTHRITIS BY USING INTERLEUKIN-17 (IL-17) ANTAGONISTS | 2016 |
|
RU2728710C2 |
METHODS FOR TREATMENT USING ANTI-IL-17A ANTIBODIES | 2016 |
|
RU2754683C2 |
METHODS OF TREATING PSORIASIS | 2008 |
|
RU2475265C2 |
METHOD OF TREATING PSORIASIS (VERSIONS) | 2009 |
|
RU2497545C2 |
AQUEOUS PHARMACEUTICAL COMPOSITION OF ANTI-IL17A ANTIBODY AND ITS APPLICATION | 2019 |
|
RU2754760C2 |
METHOD OF TREATING AUTOIMMUNE DISEASE (VERSIONS) | 2009 |
|
RU2539110C2 |
NEW INDICATIONS FOR USE IN TREATING ANTIBODIES AGAINST IL-1-BETA | 2014 |
|
RU2698208C2 |
Authors
Dates
2016-07-10—Published
2011-10-07—Filed